Chen Y, Long G, Huang Q, Zhang P, Xu N
Sci Rep. 2025; 15(1):313.
PMID: 39747533
PMC: 11695871.
DOI: 10.1038/s41598-024-84357-5.
Lin H, Cheng X, Xu Y, Wu J, Zhu J, Mao C
Neuroradiology. 2024; 67(1):153-162.
PMID: 39476126
DOI: 10.1007/s00234-024-03492-y.
Hoprekstad G, Skrede S, Bartz-Johannessen C, Joa I, Reitan S, Steen V
Brain Behav Immun Health. 2024; 37:100756.
PMID: 38549611
PMC: 10973600.
DOI: 10.1016/j.bbih.2024.100756.
Bartoli F, Calabrese A, Moretti F, Castiglioni M, Prestifilippo L, De Pietra A
Braz J Psychiatry. 2024; 46:e20233418.
PMID: 38281311
PMC: 11189112.
DOI: 10.47626/1516-4446-2023-3418.
Liu X, Liu S, Ren R, Wang X, Han C, Liu Z
Front Neurosci. 2024; 17:1286340.
PMID: 38249591
PMC: 10796775.
DOI: 10.3389/fnins.2023.1286340.
The relations between socio-demographic information and negative symptoms, mental health, and quality of life: a latent profile analysis with psychotic patients in Kosovo.
Uka F, Konjufca J, Ramadani F, Arenliu A, Berxulli D, Jovanovic N
Front Psychiatry. 2023; 14:1135385.
PMID: 37564239
PMC: 10410071.
DOI: 10.3389/fpsyt.2023.1135385.
Network analysis of comorbid depression, suicidality and biomarkers on HPA axis among mood disorder patients to psychiatric emergency services.
Wang Y, You G, Han T, Liu Y, Li J, Ji X
Transl Psychiatry. 2023; 13(1):203.
PMID: 37316541
PMC: 10267111.
DOI: 10.1038/s41398-023-02503-5.
Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
Raugh I, Luther L, Bartolomeo L, Gupta T, Ristanovic I, Pelletier-Baldelli A
Schizophr Res. 2023; 256:79-87.
PMID: 37172500
PMC: 10262695.
DOI: 10.1016/j.schres.2023.04.015.
The Associations of Neutrophil-Lymphocyte, Platelet-Lymphocyte, Monocyte-Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia.
Sagud M, Madzarac Z, Nedic Erjavec G, Simunovic Filipcic I, Mikulic F, Rogic D
Biomolecules. 2023; 13(2).
PMID: 36830666
PMC: 9952992.
DOI: 10.3390/biom13020297.
Effects of long-term supplementation of probiotics on cognitive function and emotion in temporal lobe epilepsy.
Wang X, Ma R, Liu X, Zhang Y
Front Neurol. 2022; 13:948599.
PMID: 35928136
PMC: 9343833.
DOI: 10.3389/fneur.2022.948599.
Validity and Reliability of the Staden Schizophrenia Anxiety Rating Scale.
Van Staden W, Dlagnekova A, Naidu K
Diagnostics (Basel). 2022; 12(4).
PMID: 35453879
PMC: 9028449.
DOI: 10.3390/diagnostics12040831.
Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy.
Zhang Y, Cui B, Wang T, Lu Y, Chen Z, Zou Z
Front Behav Neurosci. 2021; 15:712445.
PMID: 34776888
PMC: 8578865.
DOI: 10.3389/fnbeh.2021.712445.
Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis.
Hieronymus F, Kolbaek P, Correll C, Ostergaard S
NPJ Schizophr. 2021; 7(1):41.
PMID: 34453057
PMC: 8397783.
DOI: 10.1038/s41537-021-00168-x.
The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia.
Madzarac Z, Tudor L, Sagud M, Nedic Erjavec G, Mihaljevic Peles A, Pivac N
Curr Issues Mol Biol. 2021; 43(2):618-636.
PMID: 34287249
PMC: 8928957.
DOI: 10.3390/cimb43020045.
Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment.
Reynolds G, McGowan O
Int J Neuropsychopharmacol. 2021; 24(4):253-255.
PMID: 33882123
PMC: 8059489.
DOI: 10.1093/ijnp/pyaa091.
Effect of citalopram on hippocampal volume in first-episode schizophrenia: Structural MRI results from the DECIFER trial.
Qi W, Blessing E, Li C, Ardekani B, Hart K, Marx J
Psychiatry Res Neuroimaging. 2021; 312:111286.
PMID: 33857750
PMC: 8231472.
DOI: 10.1016/j.pscychresns.2021.111286.
Depression among Patients with Schizophrenia in Ethiopian Mental Health Hospital: Association with Sociodemographic and Clinical Variables: A Cross-Sectional Study.
Tariku M, Ali T, Misgana T, Hajure M, Asfaw H
Depress Res Treat. 2021; 2021:6697339.
PMID: 33628500
PMC: 7886508.
DOI: 10.1155/2021/6697339.
Brain imaging features in schizophrenia with co-occurring auditory verbal hallucinations and depressive symptoms-Implication for novel therapeutic strategies to alleviate the reciprocal deterioration.
Zhuo C, Fang T, Chen C, Chen M, Sun Y, Ma X
Brain Behav. 2020; 11(2):e01991.
PMID: 33305913
PMC: 7882177.
DOI: 10.1002/brb3.1991.
Socioeconomic status and the effectiveness of treatment for first-episode psychosis.
Bennett D, Rosenheck R
Health Serv Res. 2020; 56(3):409-417.
PMID: 33231881
PMC: 8143679.
DOI: 10.1111/1475-6773.13606.
Depression: An actionable outcome for those at clinical high-risk.
Addington J, Farris M, Liu L, Cadenhead K, Cannon T, Cornblatt B
Schizophr Res. 2020; 227:38-43.
PMID: 33129638
PMC: 7854482.
DOI: 10.1016/j.schres.2020.10.001.